Renoprotective action of rabeprazole and lansoprazole in gentamicin-induced nephrotoxicity: roles of oxidative stress, apoptosis, ER stress, and OCT2 expression
Abstract
Abstract Background Gentamicin (GNT)-induced nephrotoxicity involves oxidative stress, apoptosis, and enhanced renal accumulation, partly mediated by OCT2 transport activity. Proton pump inhibitors (PPIs) have been reported to exhibit nephroprotective actions beyond their gastric acid–suppressive effects. Accordingly, this study investigates the nephroprotective effects of rabeprazole (Rabe) and lansoprazole (Lanso) against GNT-induced nephrotoxicity in rats and explores their potential underlying mechanisms with particular focus on oxidative stress modulation, apoptotic signaling, endoplasmic reticulum (ER) stress regulation, and OCT2 expression. Rats were randomized into six groups: a saline control, a GNT group (100 mg/kg, ip/ eight days), two groups receiving Rabe or Lanso alone (20 mg/kg, orally / eight days), and two groups receiving Rabe or Lanso one hour before GNT for eight days. On day nine, blood and kidney tissues were collected for biochemical, molecular, and histopathological assessment. Results Both PPIs improved renal function parameters, mitigated oxidative stress, and favorably influenced key apoptotic markers. They also attenuated ER stress indicators and modulated OCT2 expression, suggesting a potential role in limiting GNT-induced renal accumulation. Histopathological evaluation further supported these biochemical findings, showing noticeable preservation of renal tubular structure in PPI-treated rats. Both agents demonstrated nephroprotective effects in…
How strong is the evidence?
Evidence Hub reads this as a randomized trial. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.